OppenheimerFunds’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $247K | Buy |
155
+3
| +2% | +$4.78K | ﹤0.01% | 1633 |
|
|
2018
Q4 | $285K | Sell |
152
-36
| -19% | -$67.5K | ﹤0.01% | 1593 |
|
|
2018
Q3 | $444K | Buy |
188
+90
| +92% | +$213K | ﹤0.01% | 1503 |
|
|
2018
Q2 | $336K | Sell |
98
-22
| -18% | -$75.4K | ﹤0.01% | 1573 |
|
|
2018
Q1 | $340K | Sell |
120
-29
| -19% | -$82.2K | ﹤0.01% | 1548 |
|
|
2017
Q4 | $383K | Buy |
149
+10
| +7% | +$25.7K | ﹤0.01% | 1600 |
|
|
2017
Q3 | $394K | Sell |
139
-56
| -29% | -$159K | ﹤0.01% | 1618 |
|
|
2017
Q2 | $462K | Buy |
195
+77
| +65% | +$182K | ﹤0.01% | 1538 |
|
|
2017
Q1 | $298K | Sell |
118
-10
| -8% | -$25.3K | ﹤0.01% | 1716 |
|
|
2016
Q4 | $288K | Buy |
+128
| New | +$288K | ﹤0.01% | 1618 |
|
|
2016
Q3 | – | Sell |
-74
| Closed | -$226K | – | 1763 |
|
|
2016
Q2 | $226K | Buy |
+74
| New | +$226K | ﹤0.01% | 1573 |
|
|
2016
Q1 | – | Sell |
-52
| Closed | -$267K | – | 1745 |
|
|
2015
Q4 | $267K | Buy |
+52
| New | +$267K | ﹤0.01% | 1566 |
|